JP2023548307A5 - - Google Patents
Info
- Publication number
- JP2023548307A5 JP2023548307A5 JP2023526131A JP2023526131A JP2023548307A5 JP 2023548307 A5 JP2023548307 A5 JP 2023548307A5 JP 2023526131 A JP2023526131 A JP 2023526131A JP 2023526131 A JP2023526131 A JP 2023526131A JP 2023548307 A5 JP2023548307 A5 JP 2023548307A5
- Authority
- JP
- Japan
- Prior art keywords
- powder composition
- patient
- composition according
- dry powder
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063106818P | 2020-10-28 | 2020-10-28 | |
| US63/106,818 | 2020-10-28 | ||
| PCT/US2021/057078 WO2022094100A1 (en) | 2020-10-28 | 2021-10-28 | Dry powder compositions of treprostinil prodrugs and methods of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026072085A Division JP2026133425A (ja) | 2020-10-28 | 2026-04-24 | トレプロスチニルプロドラッグの乾燥粉末組成物およびその使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023548307A JP2023548307A (ja) | 2023-11-16 |
| JP2023548307A5 true JP2023548307A5 (enExample) | 2024-11-07 |
| JP7857292B2 JP7857292B2 (ja) | 2026-05-12 |
Family
ID=81384296
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023526131A Active JP7857292B2 (ja) | 2020-10-28 | 2021-10-28 | トレプロスチニルプロドラッグの乾燥粉末組成物およびその使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20240285570A1 (enExample) |
| EP (1) | EP4236934A4 (enExample) |
| JP (1) | JP7857292B2 (enExample) |
| KR (1) | KR20230096998A (enExample) |
| CN (1) | CN116437906B (enExample) |
| AU (1) | AU2021369679A1 (enExample) |
| CA (1) | CA3196252A1 (enExample) |
| MX (1) | MX2023004812A (enExample) |
| WO (1) | WO2022094100A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9469600B2 (en) | 2013-10-25 | 2016-10-18 | Insmed Incorporated | Prostacyclin compounds, compositions and methods of use thereof |
| CN119632930A (zh) * | 2019-04-29 | 2025-03-18 | 英斯梅德股份有限公司 | 曲前列素前药的干粉组合物及其使用方法 |
| CN122514396A (zh) | 2023-10-30 | 2026-08-04 | 英斯梅德股份有限公司 | 药物递送装置、罩盖和药物递送方法 |
| AU2025206207A1 (en) * | 2024-01-04 | 2026-05-28 | Insmed Incorporated | Methods of treatment using dry powder compositions of treprostinil prodrugs |
| WO2025230917A1 (en) * | 2024-04-29 | 2025-11-06 | Pharmosa Biopharm Inc. | Methods for treating systemic sclerosis and frost bite by inhalation therapy |
| WO2026144627A1 (zh) * | 2024-12-31 | 2026-07-09 | 长风药业(美国)有限公司 | 一种曲前列环素衍生物的干粉组合物及其应用 |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1016489B (it) | 1974-03-18 | 1977-05-30 | Isf Spa | Inalatore |
| IT1240750B (it) | 1990-04-12 | 1993-12-17 | Chiesi Farma Spa | Dispositivo per la somministrazione di sostanze medicamentose in polvere |
| GB9015522D0 (en) | 1990-07-13 | 1990-08-29 | Braithwaite Philip W | Inhaler |
| US5785049A (en) | 1994-09-21 | 1998-07-28 | Inhale Therapeutic Systems | Method and apparatus for dispersion of dry powder medicaments |
| US6582728B1 (en) | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
| JP2924924B2 (ja) | 1992-12-18 | 1999-07-26 | シェリング・コーポレーション | 粉末薬物のための吸入器 |
| GB9306703D0 (en) | 1993-03-31 | 1993-05-26 | Fisons Plc | Inhalation device |
| SE9302550D0 (sv) | 1993-07-30 | 1993-07-30 | Ernst Hoerlin | Powder inhaler |
| PT101450B (pt) | 1994-02-02 | 1999-11-30 | Hovione Produtos Farmaceuticos | Novo dispositivo para inalacao |
| US6051256A (en) | 1994-03-07 | 2000-04-18 | Inhale Therapeutic Systems | Dispersible macromolecule compositions and methods for their preparation and use |
| FI95441C (fi) | 1994-05-31 | 1996-02-12 | Leiras Oy | Inhalointilaitteen lääkeainekammio |
| FR2725626A1 (fr) | 1994-10-18 | 1996-04-19 | Sofab | Dispositif pour l'inhalation de produits en poudre |
| SE9404439D0 (sv) | 1994-12-21 | 1994-12-21 | Astra Ab | Inhalation device |
| US6182655B1 (en) | 1995-12-07 | 2001-02-06 | Jago Research Ag | Inhaler for multiple dosed administration of a pharmacological dry powder |
| US5797392C1 (en) | 1996-01-22 | 2001-01-09 | Direct Haler As | Inhaler |
| US6026809A (en) | 1996-01-25 | 2000-02-22 | Microdose Technologies, Inc. | Inhalation device |
| US6001336A (en) | 1996-12-31 | 1999-12-14 | Inhale Therapeutic Systems | Processes for spray drying aqueous suspensions of hydrophobic drugs and compositions thereof |
| PT101988B (pt) | 1997-04-04 | 2004-02-27 | Hovione Farmaciencia Sa | Sistema de orientacao e posicionamento de um objecto |
| GB9805102D0 (en) | 1998-03-10 | 1998-05-06 | Ciba Geigy Ag | Device |
| US6257233B1 (en) | 1998-06-04 | 2001-07-10 | Inhale Therapeutic Systems | Dry powder dispersing apparatus and methods for their use |
| ES2198922T3 (es) | 1998-06-24 | 2004-02-01 | Advanced Inhalation Research, Inc. | Particulas porosas grandes emitadas por un inhalador. |
| CA2341624C (en) | 1998-08-25 | 2008-12-02 | Advanced Inhalation Research, Inc. | Stable spray-dried protein formulations |
| IT1309592B1 (it) | 1999-03-05 | 2002-01-24 | Chiesi Farma Spa | Particelle veicolo modificate da utilizzarsi nella preparazione diformulazioni farmaceutiche sotto forma di polimeri per inalazione e |
| PT1158958E (pt) | 1999-03-05 | 2007-08-13 | Chiesi Farma Spa | ''composições farmacêuticas em pó, melhoradas, para inalação'' |
| ITMI991582A1 (it) | 1999-07-16 | 2001-01-16 | Chiesi Farma Spa | Polveri costituite da particelle aventi la superficie perfettamente levigata da utilizzare come veicoli per la preparazione di miscele inala |
| WO2001068169A1 (en) | 2000-03-10 | 2001-09-20 | University Of North Carolina At Chapel Hill | Dry powder inhaler devices, multi-dose dry powder drug packages, control systems, and associated methods |
| PE20011227A1 (es) | 2000-04-17 | 2002-01-07 | Chiesi Farma Spa | Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros |
| US6766799B2 (en) | 2001-04-16 | 2004-07-27 | Advanced Inhalation Research, Inc. | Inhalation device |
| US6848197B2 (en) | 2001-04-18 | 2005-02-01 | Advanced Inhalation Research, Inc. | Control of process humidity to produce large, porous particles |
| US20040102469A1 (en) | 2002-09-13 | 2004-05-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Method for reducing the mortality rate |
| GB0222023D0 (en) | 2002-09-21 | 2002-10-30 | Aventis Pharma Ltd | Inhaler |
| US7763280B2 (en) | 2002-11-28 | 2010-07-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Tiotropium containing powder formulation for inhalation |
| CN102697790A (zh) * | 2003-05-22 | 2012-10-03 | 联合治疗公司 | 化合物和释放前列环素类似物的方法 |
| EP1522325B1 (en) | 2003-10-06 | 2007-06-13 | Bang & Olufsen Medicom A/S | Inhaler |
| CA2678258A1 (en) * | 2007-02-09 | 2008-08-14 | United Therapeutics Corporation | Treprostinil treatment for interstitial lung disease and asthma |
| US8496002B2 (en) | 2007-06-12 | 2013-07-30 | Civitas Therapeutics, Inc. | Powder inhaler devices |
| US9469600B2 (en) * | 2013-10-25 | 2016-10-18 | Insmed Incorporated | Prostacyclin compounds, compositions and methods of use thereof |
| EP3452170A4 (en) * | 2016-05-05 | 2020-04-01 | Liquidia Technologies, Inc. | TREPROSTINIL IN POWDER FORM FOR TREATING PULMONAL HYPERTENSION |
| EP3554507A1 (en) | 2016-12-14 | 2019-10-23 | Respira Therapeutics, Inc. | Methods and compositions for treatment of pulmonary hypertension and other lung disorders |
| CA3102967A1 (en) * | 2018-06-07 | 2019-12-12 | Mannkind Corporation | Composition and method for inhalation |
| CN119632930A (zh) * | 2019-04-29 | 2025-03-18 | 英斯梅德股份有限公司 | 曲前列素前药的干粉组合物及其使用方法 |
| JP2023519199A (ja) * | 2020-03-25 | 2023-05-10 | インスメッド インコーポレイテッド | トレプロスチニルプロドラッグの医薬製剤及びその使用方法 |
-
2021
- 2021-10-28 CN CN202180072519.9A patent/CN116437906B/zh active Active
- 2021-10-28 US US18/034,619 patent/US20240285570A1/en active Pending
- 2021-10-28 CA CA3196252A patent/CA3196252A1/en active Pending
- 2021-10-28 MX MX2023004812A patent/MX2023004812A/es unknown
- 2021-10-28 JP JP2023526131A patent/JP7857292B2/ja active Active
- 2021-10-28 EP EP21887529.2A patent/EP4236934A4/en active Pending
- 2021-10-28 AU AU2021369679A patent/AU2021369679A1/en active Pending
- 2021-10-28 KR KR1020237013241A patent/KR20230096998A/ko active Pending
- 2021-10-28 WO PCT/US2021/057078 patent/WO2022094100A1/en not_active Ceased
-
2023
- 2023-11-17 US US18/513,377 patent/US20240122889A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022530637A5 (enExample) | ||
| KR101653071B1 (ko) | 선별적 ｓ1ｐ₁ 수용체 작동약에 대한 투약 섭생 | |
| EP0904097B1 (en) | Combinations of vasopressin and adrenergic agents for the treatment of cardiac arrest | |
| JP4612956B2 (ja) | 抗コリン作用化合物及びβ−擬似剤に基づく新規医薬組成物 | |
| MX2023004812A (es) | Composiciones de polvo seco de profarmacos de treprostinil y metodos de uso de estos. | |
| JP2019528320A5 (enExample) | ||
| MX2024001929A (es) | Composiciones de polvo seco de profarmacos de treprostinil y metodos de uso de las mismas. | |
| JP2023522010A5 (enExample) | ||
| JP2001247459A (ja) | 癌の組み合わせ療法 | |
| JP2021514373A5 (enExample) | ||
| JP2023519199A5 (enExample) | ||
| US20170042890A1 (en) | Methods of reducing decline in vital capacity | |
| EP4494701A3 (en) | New therapeutic combinations for the treatment of progressive fibrosing interstitial lung diseases | |
| JP2023537921A5 (enExample) | ||
| US20250188082A1 (en) | Use of Hypoxanthine Compound In Preparation of Drug For Treating Pulmonary Fibrosis | |
| JP2023503380A5 (enExample) | ||
| JP7854206B2 (ja) | 肺線維症の予防または治療用の薬学製剤 | |
| JP2016506417A5 (enExample) | ||
| JP2021514380A5 (ja) | 筋障害及び骨障害を処置するための化合物及び組成物 | |
| JP2019123731A5 (enExample) | ||
| JP2023538125A5 (enExample) | ||
| Garnacho-Montero et al. | Life-Threatening Adverse Event After Amphotericin B | |
| JP2025510725A5 (enExample) | ||
| JP4784037B2 (ja) | 塩酸ランジオロールを含有する頻脈性不整脈の治療剤 | |
| JP2009526817A5 (enExample) |